Furthermore, a study revealed that the genetic variant rs9309336 may interfere with PUS10 expression, reducing tumor cell sensitivity to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). Here, PUS10 is linked to neoplasm.